RossR: The pathogenesis of atherosclerosis – an updateN Engl J Med1986, 314:488–500.
2.
von RokitanskyC. In A Manual of Pathological Anatomy, vol 4. Edited by SwaineWSievekingEMooreCDayG.Philadelphia: Blanchard & Lee; 1855:198–207.
3.
StamlerJWentworthDNeatonJ, For the MRFIT Group: Is the relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 352 222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT)JAMA1986, 256:2823–2828.
4.
MeadeTNorthWChakrabartiRStirlingYHainesPThompsonSG: Haemostatic function and cardiovascular death: Early results of a prospective studyLancet1980, i:1050–1054.
5.
MeadeT: Fibrinogen and other clotting factors in cardiovascular disease In Atherosclerotic Cardiovascular Disease, Haemostasis, and Endothelial Function. Edited by FrancisR.New York: Marcel Dekker; 1992:1–34.
6.
ErnstELudwigK: Fibrinogen as a cardiovascular risk factor: A meta-analysis and review of the literatureAnn Intern Med1993, 118:956–963.
7.
MeadeTImesonJStirlingY: Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease, Lancet1987, ii:986–988.
8.
GrayRYudkinJPattersonD: Plasminogen activator inhibitor: A risk factor for myocardial infarction in diabetic subjectsBr Heart J1993, 69:228–232.
9.
MacLeanJTomlinsonJKuangWEatonDLChenEYFlessGM: Cdna sequence of human apolipoprotein (a) is homologous to plasminogenNature1987, 330:132–137.
10.
FoltsJDRoweGG: Epinephrine potentiation of in-vivo stimuli reverses aspirin inhibition of platelet thrombus formation in stenosed canine coronary arteriesThromb Res1988, 50:507–516.
11.
GrantJScruttonM: Novel alpha-2-adrenoreceptors primarily responsible for inducing human platelet aggregationNature1979, 277:659–661.
12.
RosendaalFRVarekampISmitCBrocker-VriendsHJTDyckHVandenbrouckeJP: Mortality and causes of death in Dutch haemophiliacs 1973–86Br J Haematol1989, 71:71–76.
